Our specialty pharmaceuticals, branded generics and consumer products play a role in helping millions of people live healthier lives and providing treatment to those affected by debilitating diseases. We remain committed to improving the health and well-being of people everywhere, profitably growing our businesses, and bringing value to our shareholders.

Stock Performance

Recent Events

UBS Global Healthcare Conference

05/22/17

Bank of America Merrill Lynch 2017 Healthcare Conference

05/17/17

Q1 2017 Earnings Results

05/09/17

General Investor Relations
Elif McDonald
Director, Investor Relations
Email: ir@valeant.com
877-281-6642
514-856-3855 (Canada)